📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Delinia

1.1 - Company Overview

Delinia Logo

Delinia

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of novel therapeutics for autoimmune and inflammatory diseases, with a lead program focused on a molecule that selectively potentiates and expands regulatory T cells (Tregs), the immune cells critical to maintaining self-tolerance and immune system homeostasis.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Delinia

Cellenkos Logo

Cellenkos

HQ: United States Website
  • Description: Provider of clinical-stage allogeneic cord blood regulatory T cell therapeutics for autoimmune and inflammatory disorders, enabled by the proprietary CRANE platform for cell enrichment and differentiation and in-house cGMP manufacturing. Pipeline includes CK0801 for bone marrow failure syndromes, CK0802 for COVID-19 ARDS, and CK0804 for myelofibrosis.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Cellenkos company profile →
Triveni Bio Logo

Triveni Bio

HQ: United States Website
  • Description: Provider of genetically informed functional antibody therapeutics for immunological and inflammatory disorders, supported by a proprietary data platform that leverages public and private datasets to identify therapeutic targets, predict patient subpopulations, and provide disease insights; lead program TRIV-509 targets kallikreins 5 and 7 for atopic dermatitis and other barrier disorders.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Triveni Bio company profile →
Proteo Biotech Logo

Proteo Biotech

HQ: Germany Website
  • Description: Provider of clinical technology focused on the discovery and development of medical treatments for disease prevention.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Proteo Biotech company profile →
YorkTest Logo

YorkTest

HQ: United Kingdom Website
  • Description: Provider of food intolerance programs and diagnostic testing services, providing personalized information and support to help optimize health and wellbeing.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full YorkTest company profile →
Apellis Logo

Apellis

HQ: United States Website
  • Description: Provider of novel therapeutics and drug delivery technologies for chronic inflammatory diseases, with approved treatments SYFOVRE for geographic atrophy (a form of age-related macular degeneration) and EMPAVELI for paroxysmal nocturnal hemoglobinuria; conducts clinical trials for IC-MPGN and C3G, HSCT-TMA, and CAD; and offers compassionate use and early access programs for investigational therapies.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Apellis company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Delinia

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Delinia

2.2 - Growth funds investing in similar companies to Delinia

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Delinia

4.2 - Public trading comparable groups for Delinia

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Delinia

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Delinia

What does Delinia do?

Delinia is a provider of novel therapeutics for autoimmune and inflammatory diseases, with a lead program focused on a molecule that selectively potentiates and expands regulatory T cells (Tregs), the immune cells critical to maintaining self-tolerance and immune system homeostasis.

Who are Delinia's competitors?

Delinia's competitors and similar companies include Cellenkos, Triveni Bio, Proteo Biotech, YorkTest, and Apellis.

Where is Delinia headquartered?

Delinia is headquartered in United States.

How many employees does Delinia have?

Delinia has 1,000 employees 🔒.

When was Delinia founded?

Delinia was founded in 2010 🔒.

What sector and industry vertical is Delinia in?

Delinia is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Delinia

Who are the top strategic acquirers in Delinia's sector and industry

Top strategic M&A buyers and acquirers in Delinia's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Delinia?

Top strategic M&A buyers groups and sectors for Delinia include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Delinia's sector and industry vertical

Which are the top PE firms investing in Delinia's sector and industry vertical?

Top PE firms investing in Delinia's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Delinia's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Delinia's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Delinia's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Delinia include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Delinia's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Delinia?

The key public trading comparables and valuation benchmarks for Delinia include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Delinia for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Delinia with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Delinia's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Delinia with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Delinia's' sector and industry vertical?

Access recent funding rounds and capital raises in Delinia's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Delinia